Sunday, July 5, 2015

The Code of Medical Ethics: Truth or just another marketing cliche?

Monday, June 8, 2015, 9:46 AM
Engineers and scientists use a specific technique to test the integrity of the systems they design or study. This technique entails assessing the integrity and capacity of their systems under extreme conditions. Like any system, our healthcare establishment originated with a singular purpose –... Read more

When hospitalized, call a hospital Rapid Response Team to address unresolved safety or health concerns

Wednesday, June 3, 2015, 9:18 AM
When people suddenly become ill or injured at home or in the community, they or their families or friends can call 911 for emergency help. But who can a patient or family member call upon once they arrive at the hospital if they feel their condition is seriously deteriorating and nobody is listening?... Read more

One week, three lessons for pharma

Friday, May 29, 2015, 12:31 PM
The past week in pharma was one of those times when just setting the news items alongside one another in the proper order can tell someone a lot about the industry. Here are a few lessons to be learned from assembling the jigsaw puzzle. 1. If anyone still doubted it, the emerging markets story is... Read more

When a pharma spokesman advocates value-based pricing

Thursday, May 21, 2015, 4:55 PM
The Forbes columnist and pharma cheerleader, John La Mattina, left Pfizer in 2008 as their R&D head with a $22.6 million package after spending $1 billion of the company's money on an HDL-cholesterol enhancer that never got past the FDA. This week he wrote an item attacking two members of the... Read more

Less research training in medical school? That's actually good

Wednesday, May 13, 2015, 3:41 PM
In Sunday's Health section of the Inquirer, reporter Ilene Raymond Rush interviewed the dean of Temple's medical school, Arthur Feldman. The dean tried to advance an agenda of academic empire building by bemoaning the fact that medical students today receive less research training than in the past... Read more

Which long-term road for GlaxoSmithKline

Thursday, May 7, 2015, 9:35 AM
GlaxoSmithKline (GSK), the British pharmaceutical company with U.S. operations in the Philadelphia area, reported 2015 first quarter earnings this morning. The numbers tell a dismal story. Sales were flat compared to the same period last year, even as revenue from prescription medicines declined... Read more

Avoid heating up a pain patch

Thursday, May 7, 2015, 9:19 AM
Before leaving the hospital, a woman with bone cancer was given a prescription for a powerful pain medicine, called Duragesic. This is a medicine “patch” or “transdermal system” that adheres to the skin and slowly releases the powerful opioid fentanyl. During her first 2 weeks... Read more

Drug pricing: The problem and some band-aids

Wednesday, April 29, 2015, 12:53 PM
Two stories surfaced this week that provide more examples of how increasing drug prices have gotten totally out of hand. In the first one, a study in the medical journal Neurology tracked prices for multiple sclerosis (MS) medications during the past dozen years and uncovered an "alarming rise" that... Read more

American exceptionalism or America, Inc.?

Monday, April 27, 2015, 1:24 PM
In the year 2015, our federal government and her agencies have strayed from their intended purpose. The founding purpose and mission of the United States federal government was to protect the people from any establishment tyranny over the human spirit - from unfair usurpation of earned property and... Read more

A Citizen's Letter to Congressman Joseph Pitts of PA: Will Pitts protect patients across the nation from FDA's "mission-corruption"?

Thursday, April 23, 2015, 1:23 PM
Honorable Congressman Pitts, I understand that your colleague, Congressmen Fitzpatrick of PA, has informed you about a severe nationwide public health hazard caused by the FDA's Center for Devices and Radiological Health (CDRH). I also understand that as a chair of the House Energy and Commerce Subcommittee... Read more
About this blog

Check Up covers regional health news and a wide array of healthcare topics from pharmaceutical happenings to patient safety. Read about some of our bloggers here.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Hooman Noorchashm, M.D., Ph.D. Cardiothoracic surgeon in the Philadelphia area
Amy J. Reed, M.D., Ph.D. Anesthesiologist and Surgical Intensivist in the Philadelphia Area
Latest Health Videos
Also on
letter icon Newsletter